Prakiraan wutah bathi resik saben saham kanggo taun ngarep Kintara (KTRA)

Logo korporat perusahaan Kintara Therapeutics (KTRA)

Kintara Therapeutics (KTRA) is valued by physicians for its safe treatment methods for rare brain tumors. The company focuses on low-competition niches, developing agents against severe forms of skin and brain cancer. Patents and FDA orphan drug designations create a robust defensive barrier. The projected change in earnings per share for the coming year confirms these expectations, with the -4.20 level serving as a critical benchmark.

Kintara (KTRA): Prakiraan wutah bathi resik saben saham kanggo taun ngarep saka 04.07.2022 nganti 17.11.2026

Ringkesan rincian data analitis Kintara (KTRA)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:Kintara Therapeutics
Produk dadi Kintara Therapeutics Inc

This indicator captures the analysts' consensus forecast for earnings per share (EPS) changes, reflecting market expectations regarding future business profitability. By analyzing the projected trend of net income, investors assess fundamental optimism; for Kintara Therapeutics (KTRA), this is critical, as current quotes already price in the restructuring, and growth now depends exclusively on the success of new clinical trials.

Analisis pesaing Kintara Therapeutics

INCY (incyte.com) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep hutch-med.com HCM|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Nuvation Corp (NUVB)|DAWN - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Monopar Pharma MNPR|Inhibrx Corp - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|IMAB - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Fennec Pharmaceuticals|HRTX: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Nuvectis NVCT|Prakiraan wutah bathi saben saham kanggo taun ngarep CHRS|Prakiraan wutah bathi resik saben saham ing taun ngarep Corbus Pharmaceuticals CRBP|Prakiraan wutah bathi saben saham kanggo taun ngarep CRDF (Cardiff Oncology Inc.)|BYSI (BeyondSpring) - Dinamika bathi saben saham sing diarepake ing taun ngarep|BioAtla - Prakiraan wutah bathi saben saham kanggo taun ngarep|Proyeksi tambahing bathi saben saham ing taun ngarep LIXT (Lixte Biotechnology Holdings, Inc.)|Citius Pharmaceuticals, Inc. - Prakiraan wutah bathi kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep CLRB (Cellectar)|BLRX: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep canfite.com (CANF)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep aprea.com|KZIA: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep SLXN|Prakiraan wutah bathi kanggo taun ngarep NuCana PLC (NCNA)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Chimerix, Inc CMRX|CYCC (Cyclacel) - Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|GTHX: Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Kronos Bio Inc|oncternal.com (ONCT) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep PRTG (Portage Biotech Corp)